mdlinx mdlinx

Family Medicine - Psychiatry News & Articles

MDLinx Family Medicine stands out from other primary care literature review services because of our dedication to keeping our members current in less time. On a daily basis, receive an email with just the ‘headlines’ covering everything important that published in your specialty in the past 24 hours. Or, choose to Focus On the top articles published in the hottest topics in primary care, such as heart failure, depression, diabetes mellitus, eczema/psoriasis, infectious diseases, rheumatoid arthritis, COPD, and many more.

Additional bonus content is also available on this page, including clinical pearls from The Smartest Family Physician, a daily quiz competition from the editors of MDLinx Internal Medicine in collaboration with the Cleveland Clinic Center for Continuing Education. Additionally, enjoy the can’t-miss articles highlighted by our own physician editor, D. Scott Cunningham, MD, PhD.

Your Unread Messages in Family Medicine

See All >> Messages include industry-sponsored communications and special communications from MDLinx
New! >> Find out who is the Smartest Doc in Family Medicine!

Articles

Latest (43) Full Text Articles (848) Focus on Angina
Ranked, sorted, and summarized by MDLinx editors from the latest literature
Topics:

921 Do Novel Psychoactive Substances Displace Established Club Drugs, Supplement Them or Act as Drugs of Initiation The relationship between Mephedrone, Ecstasy and Cocaine European Addiction Research, April 22, 2013    Clinical Article

922 Evaluation of GPs diagnostic knowledge and treatment practice in detection and treatment of early schizophrenia: a French postal survey in Brittany Social Psychiatry and Psychiatric Epidemiology, April 22, 2013    Clinical Article

923 Parents experience of living with and caring for an adult son or daughter with schizophrenia at home in Ireland: a qualitative study Journal of Psychiatric and Mental Health Nursing, April 22, 2013    Clinical Article

924 A randomised, controlled trial of a dietary intervention for adults with major depression (the SMILES trial): study protocol Full Text BMC Psychiatry, April 19, 2013    Clinical Article

925 Daily Life Behaviors and Depression Risk Following Stroke: A Preliminary Study Using Ecological Momentary Assessment Journal of Geriatric Psychiatry and Neurology, April 19, 2013    Clinical Article

926 The Treatment of Depressed Chinese Americans Using Qigong in a Health Care Setting: A Pilot Study Full Text Evidence-based Complementary and Alternative Medicine , April 19, 2013    Clinical Article

927 Sense of Coherence, Depressive Symptoms, Cardiovascular Diseases, and All-Cause Mortality Psychosomatic Medicine, April 19, 2013    Clinical Article

928 Smoking-related disease risk, area deprivation and health behaviours Journal of Public Health, April 19, 2013    Clinical Article

929 Post-Traumatic Stress Disorder: Review of the Comprehensive Soldier Fitness Program American Journal of Preventive Medicine, April 19, 2013    Review Article

930 Motivations to quit cannabis use in an adult non-treatment sample: Are they related to relapse? Addictive Behaviours, April 19, 2013    Clinical Article

931 A Pilot Study Describing Physical Activity in Persons with Schizophrenia Spectrum Disorders (SSDS) after an Exercise Program Issues in Mental Health Nursing, April 19, 2013    Clinical Article

932 The effectiveness of booster sessions in CBT treatment for child and adolescent mood and anxiety disorders Depression and Anxiety, April 19, 2013    Clinical Article

933 Childhood Abuse and Neglect in an Outpatient Clinical Sample: Prevalence and Impact American Journal of Family Therapy, April 19, 2013    Clinical Article

934 Contribution of psychiatric illness and substance abuse to 30-day readmission risk Journal of Hospital Medicine, April 19, 2013    Clinical Article

935 Personality, physical activity, and symptoms of anxiety and depression: the HUNT study Social Psychiatry and Psychiatric Epidemiology, April 19, 2013    Clinical Article

936 Use and need for psychosocial support in cancer patients Cancer, April 19, 2013    Clinical Article

937 Antipsychotics can modulate the cytokine profile in schizophrenia: Attenuation of the type-2 inflammatory response Schizophrenia Research, April 19, 2013    Clinical Article

938 Step One within Stepped Care Trauma-Focused Cognitive Behavioral Therapy for Young Children: A Pilot Study Child Psychiatry and Human Development, April 19, 2013    Clinical Article

939 Spontaneous labelling and stigma associated with clinical characteristics of peers at-risk for psychosis Early Intervention in Psychiatry, April 19, 2013    Clinical Article

940 TPH1 A218C polymorphism and temperament in major depression Full Text BMC Psychiatry, April 19, 2013    Clinical Article

50 available pages First Previous 41 42 43 44 45 46 47 48 49 50 Next Last

Clinical Pearls in Family Medicine

Highlights in Family Medicine

Vitamin D supplementation decreases systemic inflammation in T2DM

In a 12-week randomized, controlled trial, ingestion of a vitamin D-fortified yogurt (170 mg calcium + 500 IU vitamin D/250 mL; n=50) twice daily decreased markers of inflammation compared with placebo yogurt (170 mg calcium; n=50). Compared with baseline measures, the 25(OH)D levels were increased and the TNF-alpha, IL-6, hsCRP, SAA, and IL-10 levels were decreased in the group supplemented with vitamin D compared with the group that received placebo.

Read the article summary

Mediterranean diet associated with decreased diabetes, cardiovascular events, and all-cause mortality

Researchers at the University of Palermo conducted a study involving 9109 subjects with a mean follow-up of 6.2 years which showed that the subjects who adhered to a Mediterranean diet had increased dietary fiber, decreased total dietary fat, and an increased intake of monosaturated-to-saturated fats. Further, the incidence of diabetes, cardiovascular events, and all-cause mortality was lower in the subjects who followed a Mediterranean diet.

Read the article summary

Natalizumab superior to IFN-? 1a in MS patients

Based on a retrospective study conducted at the Federico II University (Naples), researchers have concluded that treatment of patients (n=84) with relapsing-remitting MS natalizumab for 12-24 months resulted in a greater reduction in disease activity (annualized relapse rate, .24 vs. .55, respectively) and disability progression than patients treated with INF-? 1a. The number of contrast-enhancing lesions was also less in the natalizumab-treated group.

Read the article summary

Get reports via email to claim your reading activity at MDLinx as Category 2 CME (It takes less than a minute)

Most Popular Family Medicine Articles

Last month's top read Top Articles of 2012

Indexed Journals in Family Medicine: American Family Physician, Archives of Family Med, Annals of Family Medmore

Other Topics in Family Medicine

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Stay current - Media Tool

Newsletter
RSS
Follow Us
Facebook

Receive free subspecialty
"5-minute updates" via email

Sign up!

Send the E-mail Newsletter to a Colleague


Send

Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More

Close